Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination

Background: Identification of human papillomavirus type 16 (HPV16) as the major risk factor for cervical neoplasia, and mass production of DNA free HPV capsids have paved the way to preventive vaccination trials. Design of such trials requires reliable attack rate data. Objective: Determination of (...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kibur, M, Geijerstamm, V, Pukkala, E, Koskela, P, Luostarinen, T, Paavonen, J, Schiller, J, Wang, Z, Dillner, J, Lehtinen, M
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Group 2000
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1760571/
https://ncbi.nlm.nih.gov/pubmed/10817062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/sti.76.1.13
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk